MAML1 and cancer: MAML1 and NOTCH ternary complex (NTC) inhibitors, such as SAHM1 [81] and NADI-351 [82], respectively, capable of blocking NOTCH transcriptional complex activity, have demonstrated potential anti-cancer properties.